MyFinsight
Home
Blog
About
Back
Income Statement
NEKTAR THERAPEUTICS (NKTR)
NEKTAR THERAPEUTICS (NKTR)
source: myfinsight.com
Net loss
-$40,622,000
(2.33%↑ Y/Y)
Loss before equity
method investment
-$40,303,000
(-2.80%↓ Y/Y)
Loss from equity
method investment
-$319,000
(86.63%↑ Y/Y)
Interest income
$9,346,000
(374.66%↑ Y/Y)
Loss before
provision (benefit) for...
-$40,301,000
(-2.30%↓ Y/Y)
Provision (benefit) for
income taxes
$2,000
(101.06%↑ Y/Y)
Total non-operating
income (expense), net
$2,040,000
(164.45%↑ Y/Y)
Non-cash interest
expense on liabilities...
$7,206,000
(33.59%↑ Y/Y)
Other income
(expense), net (including...
-$100,000
(-138.46%↓ Y/Y)
Loss from operations
-$42,341,000
(-16.87%↓ Y/Y)
Total revenue
$10,131,000
(-9.34%↓ Y/Y)
Total operating costs
and expenses
$52,472,000
(10.69%↑ Y/Y)
Research and development
(including 1,137 and 613 for...
$39,129,000
(30.93%↑ Y/Y)
General and
administrative
$12,765,000
(-25.23%↓ Y/Y)
Restructuring and impairment
$578,000
(29.31%↑ Y/Y)
Back